Current research and clinical data demonstrate that NK cell therapy, with its advantages of high specificity, high safety and no obvious adverse reactions, has become a new direction for liver cancer treatment. It shows irreplaceable value especially in the treatment of intermediate and advanced liver cancer and liver cancer with high postoperative recurrence risk.